BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 1541819)

  • 1. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.
    Gazzinelli RT; Oswald IP; James SL; Sher A
    J Immunol; 1992 Mar; 148(6):1792-6. PubMed ID: 1541819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity.
    Oswald IP; Gazzinelli RT; Sher A; James SL
    J Immunol; 1992 Jun; 148(11):3578-82. PubMed ID: 1588047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.
    Gazzinelli RT; Oswald IP; Hieny S; James SL; Sher A
    Eur J Immunol; 1992 Oct; 22(10):2501-6. PubMed ID: 1396957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism.
    Anthony LS; Morrissey PJ; Nano FE
    J Immunol; 1992 Mar; 148(6):1829-34. PubMed ID: 1541823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
    Khan IA; Matsuura T; Fonseka S; Kasper LH
    J Immunol; 1996 Jan; 156(2):636-43. PubMed ID: 8543815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain.
    Scharton-Kersten T; Caspar P; Sher A; Denkers EY
    Exp Parasitol; 1996 Nov; 84(2):102-14. PubMed ID: 8932760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni.
    Wynn TA; Oswald IP; Eltoum IA; Caspar P; Lowenstein CJ; Lewis FA; James SL; Sher A
    J Immunol; 1994 Dec; 153(11):5200-9. PubMed ID: 7525727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection.
    Pemberton RM; Wilson RA
    Immunology; 1995 Feb; 84(2):310-6. PubMed ID: 7751008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
    Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kühn R; Müller W; Trinchieri G; Sher A
    J Immunol; 1996 Jul; 157(2):798-805. PubMed ID: 8752931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell clones for antigen selection and lymphokine production in murine Schistosomiasis mansoni.
    Reynolds SR; Kunkel SL; Thomas DW; Higashi GI
    J Immunol; 1990 Apr; 144(7):2757-62. PubMed ID: 1690777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite.
    Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A
    J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii.
    Kasper LH; Matsuura T; Khan IA
    J Immunol; 1995 Nov; 155(10):4798-804. PubMed ID: 7594482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction.
    Xing Z; Zganiacz A; Santosuosso M
    J Leukoc Biol; 2000 Dec; 68(6):897-902. PubMed ID: 11129658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation.
    Deckert-Schlüter M; Rang A; Weiner D; Huang S; Wiestler OD; Hof H; Schlüter D
    Lab Invest; 1996 Dec; 75(6):827-41. PubMed ID: 8973478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
    Hunter CA; Chizzonite R; Remington JS
    J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of murine macrophage function by IL-13.
    Doherty TM; Kastelein R; Menon S; Andrade S; Coffman RL
    J Immunol; 1993 Dec; 151(12):7151-60. PubMed ID: 7903102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.
    Gazzinelli RT; Wysocka M; Hayashi S; Denkers EY; Hieny S; Caspar P; Trinchieri G; Sher A
    J Immunol; 1994 Sep; 153(6):2533-43. PubMed ID: 7915739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
    Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
    J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
    Nelson BJ; Ralph P; Green SJ; Nacy CA
    J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.